Cornea biomechanics and collagen crosslinking
|
LOX |
Lysyl oxidase, participates in collagen crosslinking |
5q23.2 |
Reduced LOX expression in corneal stroma and reduced activity in KC-derived corneal fibroblasts |
Increased LOX expression and activity in retinal endothelial cells; unclear effect in DM cornea |
33,45,47,58
|
COL5A1
|
Collagen type V, alpha-1 chain
|
9q34.2-q34.3
|
COL5A1 haploinsufficiency results in corneal stroma thinning, reduced collagen fibers
|
Possible interaction between COL5A1 and HbA1c in DR study; no known direct effect on COL5A1 in cornea
|
65,66,72,81
|
ECM remodeling
|
FOXO1 |
Transcription factor |
13q14.1 |
SNP in FOXO1 linked to CCT, FOXO1 expression/activity unknown in cornea |
FOXO1 linked to AGE-mediated disruption of autophagic flux and vascular endothelial cell autophagic apoptosis, role in cornea unknown |
66,85,90
|
SMAD3 |
Transcription factor |
15q22.23 |
SNP in SMAD3 linked to CCT, Increased pSMAD3 and increased TGFβ signaling in KC cells |
SMAD3 linked to ECM remodeling in DN; role in cornea unclear |
49,98,100,106
|
TGFBI |
Transforming growth factor beta induced |
5q31.1 |
SNP in TGFBI linked to KC with decreased levels of TGFBIp in KC cornea |
Unknown effect in DM cornea, shown to be upregulated in response to high glucose and TGFβ in DM proximal tubules |
124, 125, 126,132
|
ZEB1 |
Zinc finger transcription factor |
10p11.22 |
Mutations in ZEB1 associated with KC and PPCD; possible genotype/phenotype correlation |
Unknown effect in DM cornea, implicated in epithelial-to-mesenchymal transition under hyperglycemic conditions |
152,154,155,158
|
MMP-9 |
Matrix metalloproteinase- 9 |
20q11.2-q13.1 |
Increased MMP-9 activity noted in tear sample with corresponding upregulation in MMP-9 mRNA; SNP identified in MMP-9
|
Increased MMP-9 activity in tears from DM patients; SNP identified in MMP-9 associated with T2DM susceptibility |
170,173,176,181,185
|
TIMP-1 |
Tissue inhibitor of metalloproteinases-1 |
Xp11.23 |
Decreased TIMP-1 levels detected in KC patients, SNP in TIMP-1 associated with increased KC risk |
Increased TIMP-1 levels in tears of pediatric T1DM patients, but overall role of TIMP-1 in DM remains inconclusive |
83,178,182,185
|
MIR184
|
microRNA
|
15q22-q25
|
Mutations in miR-184 implicated in KC pathogenesis, but extent of association with KC alone remains unclear
|
miR-184 expression decreased in pancreatic β –cells in response to extracellular glucose; decreased in islet cells of T2DM patients
|
187,196,200,201,310,311
|
Inflammation and ROS production
|
HGF |
Hepatocyte growth factor |
7q21.1 |
Increased HGF protein in KC corneal epithelium; increased HGF and c-Met mRNA in corneal wound healing |
Increased HGF with decreased HGF receptor c-Met expression in DM cornea |
3,214,217,220
|
CAST |
Calpain/calpastatin, proteolytic degradation |
5q15 |
SNP in CAST strongly linked to KC; CAST expression/activity unclear |
High glucose induces calpain activity, increasing ROS production and vascular endothelial dysfunction; unknown effect in cornea |
226,229,230
|
SOD1 |
Superoxide dismutase 1 cytoplasmic antioxidant enzyme |
21q22.11 |
Deletion mutation in SOD1 in several cohorts; decreased SOD1 expression in KC corneal fibroblast cultures |
Associated polymorphisms in SOD1 identified; decreased SOD1 expression in DM cornea with associated increase in RAGE |
238, 239, 240, 241,254,256
|
IL1A/IL1B
|
Interleukin 1alpha/beta, inflammatory cytokine
|
2q13
|
Increased IL-1α expression in KC corneas, SNPs identified in IL1A and IL1B
|
Imbalance in IL-1β to IL-1Ra in DM cornea, SNPs identified in IL1A, IL1B, and IL1RN in DM patients
|
119,162,203,262,268
|
Additional genes of interest
|
SPRY2 |
Sprouty 2 |
13q31.1 |
SNP in SPRY2 linked to CCT and corneal epithelium proliferation; SPRY2 expression activity in KC cornea unknown |
SNP near SPRY2 linked to increase DM susceptibility; unclear effect in SPRY2 cornea |
49,278,280, 281, 282
|
COL4A3, COL4A4 |
Collagen type IV, alpha-3/4 chain, structural portion of corneal membranes |
2q36.3 |
Alterations in collagen type IV reported in KC, but unclear if genetic polymorphisms play a role |
Alterations in collagen type IV reported in DN and in the cornea under hypoxic conditions, unknown genetic association with DM cornea |
48,283,290,291
|